Kayentis is continuing its breakthrough in the central nervous system area with new technology accessible to all and an intuitive intergenerational data collection tool which respects user customs. 

Diseases affecting the central nervous system (CNS) lead to patients losing use of their abilities (memory, muscles, mind, etc.). In the framework of clinical tests undertaken, targeting diseases such as Parkinson’s and Alzheimer’s, the sponsor is able to collect high-quality information with an effective, easy-to-use tool which requires almost no or very little training.

Kayentis is able to provide a response to this expectation by offering Clin’Form®, a solution which offers the required tools for collecting high-quality data in real time so as to significantly reduce the time required for the collection, provision and processing of data:

• Instrumented or free text areas
• Drawings
• Pain scales
• Digital data
• Scoring
• Cognitive forms : viewing time and quality of execution
• Instant visualisation of information
• Data parametering

In the framework of Parkinson’s disease, Clin’Form® enables forms to be parametered so as to obtain larger entry field areas which facilitate data collection.  Clin’Form® is therefore much simpler to use than other ePRO solutions, notably for patients with diskynesia.

Thanks to its tools which offer a vast amount of benefits for patients as well as examiners and sponsors, patients are once more placed at the heart of scientific research and this is achieved whilst concurrently reducing the period of study.  Clin’Form® allows for increased understanding of the evolution of diseases in a context where the ageing population is a major challenge for public health.

About Kayentis

Kayentis is the #1 publisher and operator of digital pen and smart paper solutions for the healthcare industry. These solutions, based on the Kayentis Digital Pen & Paper platform, combine the best of the physical and digital worlds: a very simple collection method (paper and pen) that offers the highest data reliability, plus all the advantages of electronic management (real-time data access, precise timestamping, audit trail features, alerts, and transmission of relevant information to each stakeholder). Today, Kayentis solutions have been successfully deployed in 50 countries for more than 50,000 patients. Kayentis solutions are based on Anoto Digital Pen & Paper technology; Kayentis is one of the leading world partners of Anoto, and is certified Anoto Platinum Partner. Kayentis is a member of the Pennsylvania BIO and BIO New Jersey clusters. Kayentis is an Anoto Platinum Partner, Oracle Partner and HP Solution Business Partner.